CHES1 Antibody [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-04051C
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Porcine (100%). Backed by our 100% Guarantee.
Applications
Immunoprecipitation, Western Blot
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen recognized by this antibody maps to a region between residue 440 and 490 of human Forkhead Box N3 using the numbering given in entry NP_001078940.1 (GeneID 1112).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for CHES1 Antibody [DyLight 650]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CHES1
Alternate Names
C14orf116, Checkpoint suppressor 1PRO1635, CHES1forkhead box protein N3, chromosome 14 open reading frame 116, forkhead box N3
Gene Symbol
FOXN3
Additional CHES1 Products
Product Documents for CHES1 Antibody [DyLight 650]
Product Specific Notices for CHES1 Antibody [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...